Stable, High-Yield Production
Process and strain optimization mitigate product instability and degradation, maximizing recoverable 3-HPA titer.
3-Hydroxypropionic Acid (3-HPA) is recognized as a key Bio-monomer (Acrylic Acid Precursor) for the production of commercially important derivatives, notably acrylic acid, biodegradable polymers, and 1,3-propanediol. Its production is challenged by dual issues: Chemical conversion is costly; biological yield is low, and the product is unstable. The instability of 3-HPA leads to degradation during fermentation and recovery, limiting final productivity.
CD Biosynsis focuses on stabilizing the biological route for 3-HPA: Metabolic Engineering: Introduce the Glycerol Dehydratase pathway (Glycerol to 3-HPA) into E. coli or yeast. This route efficiently converts cheap, renewable glycerol. Crucially, we address the key bottlenecks by Cofactor Balance: Optimize coenzyme B12 regeneration and NADPH supply. This ensures the continuous, high-efficiency functioning of the Glycerol Dehydratase enzyme, leading to higher, more stable 3-HPA yields.
Get a QuoteThe production of 3-HPA for industrial applications faces these critical biological and chemical challenges:
Overcoming these stability and cofactor issues is key to making bio-based 3-HPA viable.
CD Biosynsis utilizes Metabolic Engineering to stabilize the 3-HPA platform:
Glycerol Dehydratase Pathway Introduction
We introduce and optimize the Glycerol Dehydratase pathway Glycerol to 3-HPA in E. coli or yeast, using cheap Glycerol as the feedstock.
Coenzyme B12 Regeneration Optimization
We co-express B12 regeneration enzymes or develop non-B12 dependent pathways to eliminate the high cost and instability associated with B12.
Enhanced NADPH Supply
We metabolically engineer the host to overproduce NADPH e.g. via G6PDH overexpression, providing the necessary reducing power for high flux conversion.
Product Stability and Recovery Optimization
We design low-temperature fermentation protocols and in situ removal systems to prevent 3-HPA dehydration or polymerization in the broth.
Our solution ensures a sustainable, B12-independent, and stable supply of 3-HPA for bio-based Acrylic Acid production.
Our 3-Hydroxypropionic Acid 3-HPA engineering service offers these core benefits:
Stable, High-Yield Production
Process and strain optimization mitigate product instability and degradation, maximizing recoverable 3-HPA titer.
Reduced Cofactor Cost
B12-independent pathways or efficient regeneration removes the major cost bottleneck of Glycerol Dehydratase systems.
Renewable Glycerol Feedstock
Utilizing crude glycerol a byproduct of biodiesel production ensures a cheap and abundant renewable carbon source.
Sustainable Acrylic Acid Precursor
3-HPA is a direct intermediate to bio-based Acrylic Acid, replacing petrochemical Propylene in superabsorbent polymers.
High Specificity Pathway
Engineered strains exhibit minimal byproduct formation e.g. 1, 3-PDO, leading to higher purity and simplified downstream processing.
We unlock the potential of 3-HPA as a sustainable building block for the chemical industry.
Our 3-Hydroxypropionic Acid 3-HPA engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product stability attributes.
Explore the potential for a stable, high-yield 3-Hydroxypropionic Acid 3-HPA supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is 3-HPA instability such a major issue?
3-HPA can easily lose water via dehydration to form Acrylic Acid a highly toxic cell inhibitor at the temperatures used in fermentation and downstream processing. This loss not only reduces the target product yield but also poisons the microbes, halting the production run.
Why is Coenzyme B12 regeneration so important in this pathway?
The Glycerol Dehydratase enzyme uses Coenzyme B12 as a cofactor to catalyze the conversion. However, B12 is often irreversibly inactivated oxidized during the process a phenomenon called suicide inactivation. To maintain enzyme activity, the inactivated B12 must be regenerated by a dedicated reductase enzyme, which requires complex optimization.
What is the benefit of 3-HPA as an Acrylic Acid Precursor?
Currently, Acrylic Acid is produced petrochemically from Propylene a fossil fuel derivative. 3-HPA can be easily converted to Acrylic Acid through a single, mild, catalytic dehydration step. This provides a sustainable pathway for superabsorbent polymers and coatings, decoupling the supply chain from oil prices and reducing carbon emissions.
What is the estimated project timeline?
A comprehensive project involving pathway introduction, cofactor optimization, and stability improvement typically requires 35-45 weeks for final strain delivery and validated 3-HPA production protocol.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.